SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access

Recruiting now

Conditions studied: All Tumor Types

In brief

SPECTA is a quality assured platform for collecting clinicopathologically annotated biological material, imaging data, operative images, environmental assessment, questionnaires as well as patient-reported outcomes from cancer patients to support biospecimen-based translational research and clinical cancer research, including biomarker discovery to improve the understanding of tumor biology and cancer patients care.

Key facts

Study ID
NCT02834884
Run by
European Organisation for Research and Treatment of Cancer - EORTC
People needed
4975
Starts
2017-05-03
Expected to finish
2031-10-01
Last updated by the study team
2026-06-24

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.